Table 1.
Clinical characteristics of melanoma patients with available ∆ExoPD-L1 (n = 46).
| Patients N = 46 |
||
|---|---|---|
| Age, years | ||
| <70 | 28 (60.9%) | |
| =70 | 18 (39.1%) | |
| Gender | ||
| Male | 28 (60.9%) | |
| Female | 18 (39.1%) | |
| ECOG performance status | ||
| 0 | 36 (78.3%) | |
| =1 | 10 (21.7%) | |
| Anatomic location of primary melanoma | ||
| Cutaneous | 36 (78.3%) | |
| Head and neck | 7 | |
| Lower limb | 8 | |
| Upper limb | 6 | |
| Trunk | 14 | |
| Hand and foot | 1 | |
| Mucosal | 4 (8.7%) | |
| Uveal | 3 (6.5%) | |
| Unknown | 3 (6.5%) | |
| Histological subtype* | ||
| SSM | 14 (30.4%) |
|
| NM | 8 (17.4%) | |
| LMN | - | |
| ALM | 1 (2.2%) | |
| Desmoplastic | 1 (2.2%) | |
| Unknown | 12 (26.1%) | |
| NA | 10 (21.7%) | |
| Breslow, mm* | ||
| 0–1 mm | 7 (15.2%) | |
| 1.01–2 mm | 7 (15.2%) | |
| 2.01–4 mm | 12 (26.1%) | |
| =4 mm | 9 (19.6%) | |
| Unknown | 1 (2.2%) | |
| NA | 10 (21.7%) |